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Na+/H+ exchangerThe mammalian Na+/H+ exchanger isoform 1 (NHE1) is a ubiquitously expressed plasma membrane pro-
tein. It regulates intracellular pH by removing a single intracellular H+ in exchange for one extracellular
Na+. The membrane domain of NHE1 comprises the 500 N-terminal amino acids and is made of 12 trans-
membrane segments. The extracellular loops of the transmembrane segments are thought to be involved
in cation coordination and inhibitor sensitivity. We have characterized the structure and function of amino
acids 278–291 representing extracellular loop 4. When mutated to Cys, residues F277, F280, N282 and
E284 of EL4 were sensitive to mutation and reaction with MTSET inhibiting NHE1 activity. In addition they
were found to be accessible to extracellular applied MTSET. A peptide of the amino acids of EL4 was mostly
unstructured suggesting that it does not provide a rigid structured link between TM VII and TM VIII. Our re-
sults suggest that EL4 makes an extension upward from TM VII to make up part of the mouth of the NHE1
protein and is involved in cation selectivity or coordination. EL4 provides a ﬂexible link to TM VIII which
may either allow movement of TM VII or allow TM VIII to not be adjacent to TM VII.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
A key pH regulatory protein in mammalian cells is the Na+/H+ ex-
changer, type I isoform (NHE1). NHE1 is a ubiquitous plasma mem-
brane protein that catalyzes removal of a single intracellular proton
in exchange for a single extracellular sodium ion [1–3]. Aside from
regulation of intracellular pH, NHE1 has numerous other indirect
physiological roles. It promotes cell growth and differentiation [4], fa-
cilitates inward sodium ﬂux in response to osmotic shrinkage [5], and
enhances cell motility [6]. Additionally, NHE1 has several pathological
roles. Studies in culture have suggested that NHE1 may be important
in breast cancer cell invasiveness and have demonstrated that in
NHE1 activity enhances invasion by breast cancer cells not only by
raising intracellular pH, but also by acidiﬁcation of the extracellular
microenvironment of tumor cells [7–10]. The extracellular acidiﬁca-
tion may be necessary for protease activation which facilitates the di-
gestion and remodeling of the extracellular matrix [8], critical in
metastasis.
In the myocardium it promotes heart hypertrophy and exacerbates
the damage that occurs during myocardial ischemia and reperfusion.acellular loop; HA, hemagglu-
; MTSES, ([2-Sulfonatoethyl]
)ethyl] methanethiosulfonate);
, 347 Medical Science Building,
2H7. Tel.: +1 780 492 1848;
rights reserved.Inhibitors of NHE1 have proven useful in preclinical trials, for protecting
the myocardium in various disease states [11–14]. However clinical
trials with NHE1 inhibitors have been disappointing, possibly due to a
lack of speciﬁcity of the inhibitors [15]. Further knowledge of NHE1
structure and function may facilitate the development of more speciﬁc
inhibitors for clinical use.
The mammalian NHE1 protein is believed to consist of 12 trans-
membrane (TM) segments that comprise the N-terminal 500 amino
acids. These are connected by a series of extra membrane segments
which form intracellular and extracellular loops (EL). Loops between
α-helices can inﬂuence their arrangements and packing [16] and can
modulate protein function [17]. For NHE1, EL5 may be involved in
drug sensitivity and cation binding [18,19]. EL2 links TM segments I
and II and mutation of residues of EL2 affects both the drug sensitivity
and the activity of NHE1 [20,21]. Two models of the topology of NHE1
are in question with two different models, one model is based on cys-
teine accessibility studies [22] and a second being based on computa-
tional comparison with the deduced structure of the Escherichia coli
Na+/H+ exchanger NhaA suggested [23]. Although signiﬁcant varia-
tion in the predictions occurs after amino acid 315, prior to this region
the models are essentially identical with the exception of the latter
model predicting that the ﬁrst two transmembrane segments are
cleaved free of the protein. Amino acids 278–290 are predicted to
form an EL in both models. They form EL4 connecting TM VII and
VIII in the model of Wakabayshi et al. [22] and are predicted to
form the same loop in the model of Landau et al. [23] connecting
the same two transmembrane segments that are numbered V and
VI in that model. Little is known about this particular loop connecting
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terms of its functional role and contribution by the amino acids pres-
ent in it. We have earlier examined the structure and function of TM
VII. We found that TM VII is a predominantly α-helical segment, that
is critical to NHE1 function and that it contained pore lining residues
[24,25].
ELs of transporters are often critical to their function. For example
in the serotonin transporter, the glutamate transporter and the gly-
cine transporter [26–28] ELs play key roles in function. For Na+,K+
ATPase the second EL is a major determinant of extracellular cation
afﬁnity [29,30]. Amino acids of the acetylcholine receptor [31,32]
and NhaA [33] ELs are also involved in the attraction of cation to the
extracellular surface. In this study we examined the role of EL4
(amino acids 274–290) of the NHE1 isoform of the mammalian
Na+/H+ exchanger. We also used NMR to characterize the structural
properties of synthetic peptides representing EL4.
2. Materials and methods
2.1. Materials
Streptavidin–agarose resin was from Sigma-Aldrich (St. Louis, MO,
USA). Toronto Research Chemicals, (Toronto, Ontario, Canada) supplied
MTSET and MTSES. Lipofectamine™ 2000 reagent was purchased from
Invitrogen (Carlsbad, CA, USA) and PWODNApolymerasewas obtained
from Roche Applied Science (RocheMolecular Biochemicals, Mannheim,
Germany). Sulfo-NHS-SS-biotin was from Pierce Chemical Company
(Rockford, IL, USA).
2.2. Site-directed mutagenesis
For expression and mutagenesis of the human NHE1 protein we
used the expression plasmid pYN4+ that contains a fully functional
hemagglutinin (HA) tagged human NHE1 isoform of the Na+/H+ ex-
changer with all native cysteines mutated to serine [34]. Mutations to
the NHE1 cDNA in pYN4+ changing the indicated amino acids to cys-
teine (Supplementary Table 1), where indicated, were made using the
functional cysteineless NHE1 protein that we described earlier [35].
We have characterized amino acids 271–273 as part of our earlier
work on TM VII [25]. Site-directedmutagenesiswas as described earlier
[35]. Mutations were designed to create or delete a restriction enzyme
site. DNA sequencing conﬁrmed the ﬁdelity of DNA ampliﬁcation and
mutations.
2.3. Cell culture and transfections
Stable cell lines were made using AP-1 cells transformed with con-
trol and mutant pYN4+Cysless DNA [19]. AP-1 cells lack their endog-
enous Na+/H+ exchanger as described earlier. Transfection was with
Lipofectamine™ 2000 Reagent (Invitrogen Life Technologies, Carlsbad,
CA, USA) [34]. Stable cell lines for experiments were regularly
re-established from frozen stocks at passage numbers between 5 and
9. At least two independently made clones of each mutant were made
and results are shown from one mutant. Independently made clones
all had very similar functional characteristics.
2.3.1. SDS-PAGE and immunoblotting
Cell lysates were made as described earlier [34] and were used for
Western blot analysis on 10% SDS/polyacrylamide gels [36]. Identiﬁ-
cation of the NHE1 protein was via the hemagglutinin (HA) tag on
the Na+/H+ exchanger using an anti-HA monoclonal antibody. The
second antibody was peroxidase-conjugated goat anti-mouse anti-
body. Chemiluminescence was used to visualize immunoreactive pro-
teins. Quantiﬁcation was using ImageJ 1.35 software (National
Institutes of Health, Bethesda, MD, USA) examining protein expres-
sion on X-ray ﬁlms.2.4. Cell surface expression
The amount of NHE1 protein that was targeted to the cell surface
was measured essentially as described earlier [34]. Brieﬂy, cell sur-
faces were labeled with sulfo-NHS-SS-biotin and immobilized
streptavidin was used to remove plasma membrane labeled NHE1
protein. Equivalent amounts of total and unbound proteins were an-
alyzed by blotting for HA-tagged NHE1 protein. It was not possible
to efﬁciently and reproducibly elute proteins bound to immobilized
streptavidin resin. The relative amount of NHE1 on the cell surface
was calculated for both the 110 kDa and the 95 kDa (partial or
de-glycosylated) HA-immunoreactive species in Western blots of
the fractions as indicated in the ﬁgures and legends.
2.5. Accessibility of EL4 residues
The accessibility of residues of EL4 was determined based on a
modiﬁed procedure of [37]. Stable cell lines with mutants of EL4
were grown to conﬂuence and after washing with phosphate buffer
saline (PBS), were treated with or without 10 mM MTSET for
20 min at 37 °C in a buffer consisting of 135 mM NaCl, 5 mM KCl,
1.8 mM CaCl2, 1.0 mM MgSO4, 5.5 mM glucose and 10 mM HEPES,
and pH 7.3 (normal buffer). Cells were washed with PBS three times
and then 2 ml of a lysis buffer was added, consisting of 25 mM Tris
HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 5% glycerol and
37.5 μM ALLN and a protease inhibitor cocktail described earlier
[38]. Cells were scraped off and sonicated two times for 15 s. The so-
lution was spun at 35,000 rpm (100,000 ×g) for 1 h and the superna-
tant was collected. The supernatant was used to immunoprecipitate
the HA-tagged NHE1 protein. For this purpose we used the Pierce
Crosslink IP kit in which the primary antibody was crosslinked to Pro-
tein A/G agarose enabling immunoprecipitation without contamina-
tion from the primary antibody. The primary antibody used for
immunoprecipitation was a commercially obtained rabbit polyclonal
(Santa Cruz, sc-805). After immunoprecipitation, the sample was di-
vided into two. One sample was used to quantify the total NHE1 pro-
tein via western blotting. To the second sample IRDye800-maleimide
(LI-COR) was added (ﬁnal concentration 0.2 mM) which would react
with any unblocked sulfhydryls of the introduced cysteine. Samples
were separated by SDS-PAGE and we examined the protein reacting
with the IRDye800-maleimide using the LI-COR system. MTSET acces-
sibility=100−%(Fluorescence in the presence of MTSET/Fluores-
cence in absence of MTSET). Readings were corrected for the
amount of NHE1 immunoprecipitated by Western blotting for NHE1
with a monoclonal antibody against the HA tag.
2.6. Na+/H+ exchange activity
Na+/H+ exchange activity was measured as described earlier
[25] using a spectroﬂuorometer and the pH sensitive dye 2′,7-bis
(2-carboxyethyl)-5(6) carboxyﬂuorescein-AM (Molecular Probes
Inc., Eugene, OR, USA). Ammonium chloride induced an acute acid
load as described earlier [39]. The initial rate of Na+ (135 mM)-induced
recovery of cytosolic pHwasmeasured as described earlier [25]. Buffer-
ing capacities of stable cell lines did not vary and the initial recovery rate
measuredwas from equivalent initial pHs.Wherever indicated, NHE ac-
tivity was corrected for the level of protein expression and for the
targeting of the protein to the cell surface. To determine reactivity
with externally reactive sulfhydryl compounds, cells were treated
with MTSET or MTSES using a two-pulse acidiﬁcation assay. Cells
were treatedwith ammoniumchloride two times and allowed to recov-
er twice in NaCl containing medium [35]. The ﬁrst pulse was in the ab-
sence of inhibitor and the second pulse was performed after the cells
were treated with either 10 mM MTSET or MTSES for 10 min in NaCl
containing buffer. The starting pH of recovery was equivalent in the
two pulses. The rate of recovery in the absence of inhibitor was
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for residual activity was
% residualactivity ¼ pH change after Reagentð Þ  100%:
pH changew=o Reagentð Þ
Results are shown as mean±SE. Statistical signiﬁcance was deter-
mined using a Mann–Whitney U test.
2.7. Peptide synthesis, puriﬁcation and preparation
Linear and cyclic peptides representing EL4 (sequence acetyl-
YHLFEEFANYEHVGIVDI-amide, and disulﬁde-cyclicized acetyl-
CGYHLFEEFANYEHVGIVDIFLGFLC-amide), were purchased from
GL Biochem (Shanghai) Ltd. The peptide was puriﬁed by HPLC using in
house services of the Institute for Biomedical Design. The identity of the
peptide was conﬁrmed by using matrix-assisted laser desorption ioniza-
tionmass spectrometry andby sequential assignment of theNMRspectra.
Samples for NMR structure determination contained 1.0 mM of
puriﬁed peptide dissolved in DMSO-d6. The linear and cyclic peptide
samples were at temperatures of 30 °C and 35 °C, respectively. Spec-
tra were referenced so that the residual DMSO (CH3)2 peak is at
2.50 ppm. 2D 1H–1H DQF–COSY, TOCSY, and NOESY spectra were
taken on either 500 MHz or 800 MHz NMR spectrometers. Spectra
were processed with NMRPipe [40] and sequential assignment [41]
was performed in NMRViewJ [42].
3. Results
3.1. Characterization of EL4 mutants
Fig. 1 illustrates a model of EL4 and shows the amino acids present.
EL4 consists of residues Y274–I291. It contains several acidic residues
and a mixture of hydrophilic and hydrophobic amino acids. EL4 wasFig. 1.Models of EL4 of the NHE1 isoform of the Na+/H+ exchanger. Topological model
of the EL4 of the transmembrane domain of the NHE1 isoform of the Na+/H+ exchang-
er. TM segment numbering is based on cysteine accessibility studies [22].initially studied by a combination of site speciﬁcmutagenesis and cyste-
ine scanning mutagenesis. The acidic residues of EL4, E278, E279, E284
and D290, were changed to their corresponding non-charged amino
acids, E to Q and D to N in individual mutant proteins. Also, all the
amino acids of EL4 were changed to cysteine in the background of the
cysteineless NHE1 (cNHE1) protein.Weﬁrst determined the expression
levels, targeting and activity of the mutant NHE1 proteins. Fig. 2A–C il-
lustrates these results. Expression levels were determined by western
blotting with antibody against the HA tag on the Na+/H+ exchanger
protein. Fig. 2A demonstrates that all the mutant proteins were
expressed. As shown earlier [35], NHE1 was expressed as a fully
glycosylated and a partial or de-glycosylated protein and these two im-
munoreactive bands were present in all stable cell lines. Expression of
several of the mutants was reduced. Most notably, the E279Q and
Y283C protein levels were less than 10% of the level of cNHE1. The mu-
tants Y274C, L276C, V286C and I291C also had reduced expression that
was between 50 and 30% of cNHE1.Most othermutants had some slight
decrease in expression compared to controls, though a few (D290N,
H275C, F277C, E279C, F280C) were equivalent to cNHE1. For both the
E279Q and the V286C mutants, aside from their lower levels of expres-
sion, it was notable that a larger percentage of the expressed protein
was present as the unglycosylated form.
Wenext examined the targeting of themutant proteins to the cell sur-
face. Cell surface biotinylation experiments were done as described earli-
er [25]. The results are shown in Fig. 2B. The mutant proteins targeted
well to the cell surface. Thoughminor variations occurred in the efﬁcien-
cy of targeting, thesewere not nearly as large aswe have observed earlier
with mutations of transmembrane regions of the NHE1 protein [34,35].
Determination of the activity of the EL4mutants showed thatmost of
the mutants had reduced activity relative to either the wild type or
cysteineless NHE1 protein. With the exception of the G287C and I288C
mutants, all of the activity was less than half of that of the control
(Fig. 2C). The uncorrected activity of the E279Q, Y274C, L276C, Y283C
and V286Cmutants was less than 10% of the control level and these mu-
tantswere considered inactive or nearly so, andwere not used for further
study. For the E279Q and the Y283Cmuch of the decrease inmeasurable
activity was due to a decrease in the expression level of the protein,
though the residual activity was too low for further characterization.
We determined the effect of MTSET and MTSES on the activity of
the remaining active cysteine mutants. The results are shown in
Fig. 3. Mutant F277C was exquisitely sensitive to inhibition by posi-
tively charged MTSET, but not to inhibition by negatively charged
MTSES. Mutants F280C, N282C and E284C were all also partially sen-
sitive to inhibition by MTSET while only mutant F280C was partially
sensitive to inhibition by MTSES.
It is possible that some Cys residues were reactive with MTSES or
MTSET but that this was not inhibitory to NHE1 activity. We therefore
measured the accessibility of the active cysteine mutants. The results
are shown in Fig. 4. Residues thatwere inhibited byMTSETwhen changed
to Cys (F277, F280, N282, E284)weremore accessible toMTSET and incu-
bation with MTSET blocked reactivity with IRDye800-maleimide. The
F280C mutant protein was less accessible than the F277C, N282C and
E284C containing proteins, but was more accessible than other residues.
3.2. Characterization of EL4 protein
We purchased two chemically synthesized peptides containing the
EL4 sequence for high-resolution NMR spectroscopy. The ﬁrst peptide
was a linear peptide containing Y274–I291 of EL4,withN-terminal acetyl
and C-terminal amine caps to remove the charges at the peptide termini.
A second peptide of the sequence acetyl-CG-Y274-L296-C-amine was
also synthesized. Additional residues on the C-terminal end of this sec-
ond peptide corresponded to the slight difference in prediction of the lo-
cations of the transmembrane helices between the topology models
proposed by [22] and [23]. The peptide also contained disulﬁde-linked
cysteines at the termini to produce a cyclic peptide, which may restrict
Fig. 2. Analysis of wild type NHE1 and mutant EL4 proteins. A, Western blot of whole cell lysates of stable cell lines expressing Na+/H+ exchanger EL4 mutants or control protein.
Mutations are as indicated. 100 μg of total protein was loaded in each lane. Numbers below the lanes indicate the amount of NHE1 protein relative to wild type NHE. Mean values
(n=3–4) were obtained from densitometric scans of both the 110 and 95-kDa bands. AP-1 refers to AP-1 cells mock transfected. Wt, and cNHE1 refer to cells stably expressing wild
type Na+/H+ exchanger protein and the cysteineless NHE1, respectively. B, Surface localization of NHE1 in AP-1 cells expressing control and EL4 mutants. Equal amounts of total
cell lysate (left lane) and unbound intracellular lysate (right lane) were examined byWestern blotting with anti-HA antibody to identify NHE1 protein. WT and cNHE1 are cell lines
stably expressing wild type NHE1 and cysteineless NHE1, respectively. The percent of the total NHE1 protein found on the plasma membrane is indicated for each mutant. For Ct this
indicates the amount of non-speciﬁc binding to streptavidin–agarose beads. Results are the mean±the S.E. n=at least 4 determinations. Autoradiography exposure times were
increased for mutants expressing lower levels of protein. C, Summary of the rate of recovery after an acute acid load of AP-1 cells transfected with wild type NHE1, cNHE, and
EL4 Na+/H+ exchanger mutants. The mean activity of cNHE1 stably transfected with NHE1 was 1.7 Δ pH/min, and this value was set to 100% and other activities are a percent
of those of cNHE. Values are the mean±SE of 6–10 determinations. Results are shown for mean activity of both uncorrected (black) and normalized for surface processing and
expression levels (gray).
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Fig. 3. Effect of sulphydryl reactive compounds, MTSET andMTSES, on activity of cNHE1 and
single cysteine NHE1mutant containing cell lines. A, Example of results of effect ofMTSET on
activity of cNHE1 and F277C NHE1 mutant. NHE1 protein activity was assayed in stably
transfected AP-1 cells as described in the “Materials and methods”. Activity was measured
after two acidpulses. Theﬁrst pulse illustratedwas in the absence ofMTSET. For ease of view-
ing, only the recovery fromacidosis is shown for the secondpulse, inwhich cellswere treated
with MTSET.NH4Cl, treatment with ammonium chloride. After NH4Cl treatment, there was a
brief Na Free treatment to induce acidosis. NaCl, time when recovery from acidosis was in
NaCl containing buffer, for the second pulse this contained MTSET as indicated and cells
were pretreated with MTSET for 10 min prior to NH4Cl induced acid load. B, Summary of ef-
fects of MTSET andMTSES on NHE activity of EL4mutants. Activity was measured after dual
ammonium chloride pulses as described in the “Materials and methods”. The second acidiﬁ-
cationwas after cellswere treatedwith10 mMMTSETorMTSES. Results are presented as the
% of activity of the second acid load, relative to the ﬁrst. * indicates that the second recovery
from acid load was signiﬁcantly lower than the ﬁrst at *Pb0.05. Solid ﬁlled bars represent
MTSET treatments and hatched bars are MTSES treatments.
2787B.L. Lee et al. / Biochimica et Biophysica Acta 1818 (2012) 2783–2790the conformations adopted by the extracellular loop, anda glycine spacer
at the N-terminal end to increase the distance between the ends of EL4.
These were designed to link the N and C-terminals of the peptide, mim-
icking a putative association between transmembrane segments VII and
VIII.
1D 1H NMR spectra were used to judge the quality of the samples of
solubilized EL4 for structure determination. Spectra of the linear pep-
tide in aqueous buffer (50 mM imidazole, 100 mM KCl, 10% D2O,
0.25 mMDSS-d6) suggested that the peptidewas unstructured in aque-
ous solution. HNandHα peaks in the 1D spectrawere distributed over a
very narrow range, 8.0–8.4 ppm and 4.1–4.3 ppm, respectively. Addi-
tion of up to 20% TFE-d3 did not affect the dispersion of the HN and
Hα peaks and again suggested that the peptide was unstructured. The
peptide sample was lyophilized and reconstituted in DMSO-d6, where
there appeared to be an improvement in the dispersion of the peaks,
suggesting it may be more structured in DMSO. 2D NMR spectra were
then acquired for assignment and structure determination. The cyclic
peptide was found to be insoluble in H2O and TFE/H2O, but was soluble
in DMSO. NMR spectra were also acquired for this peptide in DMSO.
Differences in the quality of the spectra could be observed be-
tween the linear and cyclic peptides. Spectra of the linear peptide
contained relatively narrow peaks, while the spectra of the cyclic pep-
tide contained broad peaks as shown by the amide regions of the 1D
NMR spectra (Fig. 5). Both peptides could be fully assigned. The cyclic
peptide also contains additional unassigned peaks that may have
been either impurities or minor conformations of the peptide.
TheNMR spectra suggest that despite the increased dispersion of the
peaks in DMSO compared to aqueous solution, the peptide is stillmostly
unstructured in DMSO. There is poor chemical shift dispersion in theHα
dimension, as shown by the 2D DQFCOSY spectra (Fig. 5) with the
non-glycine Hα peaks limited to 4.1–4.6 ppm in both the linear and cy-
clic peptides. The NOESY spectra of both peptides contained weak
intraresidue HN–Hα peaks and strong sequential Hα–HN connectivi-
ties, and generally lack medium and long range connectivities, also in-
dicative of poorly structured peptides. A comparison of Hα chemical
shift values with published random coil chemical shift valuesmeasured
in H2O [43] and DMSO [44] also suggest that the peptides are relatively
unstructured in solution (Fig. 6). Continuous regions of large negative
chemical shift differences suggest alpha-helical content, while positive
values would suggest beta-sheet content. Neither of the peptides
shows any contiguous segments with either strong negative or positive
values, again suggesting that the peptides are relatively unstructured.
The similarities in the chemical shifts and chemical shift differences be-
tween the linear and cyclic peptides suggest that they may also be
adopting similar, if relatively unstructured, conformations, despite the
restraint provided by the disulﬁde bond in the cyclic peptide.
4. Discussion
4.1. Critical residues of EL4
In this study we examined EL4 of the NHE1 isoform of the Na+/H+
exchanger, examining the residues critical in function, their accessibility
and the structure of EL4. There has been some previous relatedwork [22]
that examined the topology of NHE1 and the accessibility of a few resi-
dues of EL4. Mutation of amino acids E278 to H285 to Cys resulted in a
protein inwhich all thesemutants were all shown to be accessible extra-
cellularly. In addition that study examined the effect of external MTSET
on NHE1 activity. They found some similar but some different results
from our study. Similar to their study, we found slight inhibitory effects
of MTSET on the N282C mutant protein. However, we found many
other differences. In contrast to their results, we found no signiﬁcant in-
hibitory effect ofMTSET on theA281Cmutant. It should be noted that the
effect ofMTSET thatwas found earlierwas very small. Another difference
between their study and ours is that we found signiﬁcant effects of
MTSET on the E284C protein and of both MTSET and MTSES on the
Fig. 4. Accessibility of residues of EL4 to reactivity withMTSES. The accessibility of the
residues of EL2 to reactivity with MTSET was measured as described in the “Materials
and methods”. A, Examples of results illustrated MTSET blocking of reactivity with
IRDye800-maleimide. Prior reaction with MTSET blocks the reactivity with
IRDye800-maleimide. + indicates reacted with MTSET prior to reaction with
IRDye800-maleimide. B, Summary of the results illustrating calculated accessibility
of residues of EL4. Results are the mean±SE of at least 3 experiments.
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F277C mutant protein (which was not examined in that study) was
inhibited most strongly by MTSET. Why they did not detect effects of
MTSET on the F280C protein is uncertain at this time. However we
found a signiﬁcant, reproducible inhibitory effect of MTSET and in addi-
tion, this residue was accessible to MTSET. We noted that accessibility
of the F280Cmutant protein was temperature sensitive, and was greatly
reduced at 30 °C (not shown). It should be noted that the earlier study
examined NHE1 activity using a radioisotope assay examining Na+ up-
take. The present assay, examining rapid kinetics of NHE1 in a dual
pulse system,would likely bemore sensitive and detect changes in activ-
ity that might not be detectable using a radioisotope assay. Of note, we
found that the F277C mutant protein was the most reactive protein
withMTSET, in our accessibility assay (Fig. 4), further conﬁrming the re-
sults of the activity measurements.
We also found that with the exception of mutant F280C, positively
charged MTSET was inhibitory while negatively charged MTSES was
without effect. If EL4 is an external region of the NHE1 protein in-
volved in cation coordination, it would appear reasonable that addi-
tion of a positively charged compound would be more inhibitory,
possibly repelling a cation at the mouth of the protein. In the case of
the F280C mutant protein, while MTSET was greatly inhibitory, nega-
tively charged MTSES was also strongly inhibitory, though not as
much as MTSET. In this case, effects on ion passage by MTSES are like-
ly due to a steric hindrance caused by the addition of the bulky com-
pound and are not charge related. Another mutant protein, the F277C
mutant, was the most strongly inhibited by MTSET. We suggest that
this side chain of this amino acid was more directly pointing toward
the mouth of the extracellular cation funnel of the NHE1 protein.
Therefore, its linkage to the positively charged MTSET more effective-
ly caused inhibition of cation coordination in the mouth of the NHE1
protein. Overall, our study suggests that the residues F277, F280,
N282 and E284 form an important part of the extracellular pore of
NHE1. Mutation of the adjacent residues L276 and Y283 to Cys caused
an inactive protein, suggesting they may also play an important part
of the extracellular pore of NHE1. While further study of these resi-
dues is called for, clearly the side chain of these amino acids must
be within certain constraints that were not met by substitution to Cys.
We also made mutations to eliminate the negative charge on
amino acids E278, E279, E284 and D290. In all cases activity was re-
duced but not eliminated. For the mutant protein with the E279Qmu-
tation, the decrease in activity was largely due to a reduction in the
level of protein expression. We had hypothesized that having nega-
tively charged side chains, these amino acids might be critical in cat-
ion attraction. However for these amino acids this does not appear to
be the case. Nevertheless, it is apparent that only amino acid E279 is
important of these, and the effects were mainly on protein expres-
sion. An effect on protein conformation or processing may occur.
4.2. Analysis of EL4 structure and function
High-resolution NMR analysis of the linear and cyclic EL4 peptides
suggests that both peptides adopt mostly random-coil conformations in
DMSO. DMSO has an intermediate dielectric constant (~46) [45] similar
to themembrane interface [46],making it a reasonablemimetic of the en-
vironment experienced by the loop. A study by Kattragadda et al. [47]
showed that the NMR structures of isolated loops frombacteriorhodopsin
inDMSOadopt structures equivalent to the known crystal structure of the
protein. Other studies [48–50] including our own on EL2 of NHE1 [20],
have also found structures in interhelical loops in aqueous solution or
DMSO. However, this was not the case for EL4 of NHE1. It is unlikely
that the length of the peptides we studied is the reason for the lack of
structure, as the other studies on isolated loops haveusedpeptides of sim-
ilar lengths. The lack of structure could suggest that the loop is ﬂexible,
which could be important in the function of NHE1. Alternatively, the
loop may only be structured in the full protein, where interactions withother extracellular regions of the protein and with the membrane bilayer
could restrict the conformation of the loop. However to address this pos-
sibility we examine the EL4 peptide with its ends tethered by a disulﬁde
bond. Even in this case we did not ﬁnd a structured peptide. In the
three-dimensionalmodel of NHE1proposedby Landau et. al [23] EL4 con-
nects the transmembrane helices 5 and 6 of this model (corresponding to
TM VII and TM VIII of the other model). The Landau et al. model does not
suggest any interactions with each other. The lack of structure in the loop
could be to allow the helices to be some distance apart from each other.
Our data are somewhat contradictory to a recent 3D model which
did not place VII and VIII surrounding the catalytic core of the protein
[51]. However, that model did not directly provide evidence for the lo-
cation of these transmembrane segments and was largely based on ho-
mology modeling. We have earlier demonstrated that TM VII possesses
several amino acids that when changed to Cys, are sensitive to derivati-
zation with MTSET and affect protein function [24,25]. In addition, mu-
tation of residues of TM VII altered sensitivity to NHE1 speciﬁc
inhibitors [25]. Additionally, E262 of TM VII is exquisitely sensitive to
mutation and changing that residue to an Asp, alters the afﬁnity of the
NHE1 protein to Li+ but not for Na+, suggesting that this amino acid
is involved in cation coordination [19]. TM VII also has a ﬂexible middle
region from amino acids G261–S263 which may allow conformation
changes associated with movement during transport [25,52]. These
data all support a role for this transmembrane segment in NHE1 func-
tion which is consistent with a functional role for EL4 in the pore of
the NHE1 protein.
Fig. 5. 1D 1H and 2D 1H–1H DQFCOSY spectra of the linear and cyclic EL4 peptides in DMSO. The HN–Hα “ﬁngerprint” region of the 2D DQFCOSY spectra of the linear and cyclic
peptides is shown. Above are the corresponding HN regions of the 1D NMR spectra of the peptides. Spectra for the linear peptide were acquired at 500 MHz and 30 °C, and
800 MHz and 35 °C for the cyclic peptide, and referenced to the DMSO peak at 2.50 ppm.
2789B.L. Lee et al. / Biochimica et Biophysica Acta 1818 (2012) 2783–27904.3. Conclusion
Overall, our results support a model in which TM VII is important in
the catalytic core of the protein and amino acids 274–284 of EL4 makeFig. 6. Chemical shift index values for the linear and cyclic EL4 peptides in DMSO. Differen
random coil Hα chemical shifts in water [53] and DMSO [44] are shown per residue. Contig
itive secondary shifts suggest beta sheet content. Regions exceeding the cutoff value of−0.1
content [54].an extension upward from TM VII to make up part of the mouth of the
protein. A ﬂexible connection from TM VII to TM VIII may allow TM
VII to make conformational changes associated with its postulated
role in transport [52]. F277, F280, N282, E284 are in particular shownces in Hα chemical shift between observed Hα values for the peptides and published
uous regions of large negative secondary shifts suggest helical content while large pos-
ppm (dotted line) when using random coil values determined in water suggest helical
2790 B.L. Lee et al. / Biochimica et Biophysica Acta 1818 (2012) 2783–2790to be critical as demonstrated by the inhibitory effect shownwhenmu-
tated to Cys and reacted with positively charged MTSET.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamem.2012.06.021.Acknowledgments
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